Comments to FDA: CPSIA Share page: CHPA comments on the “Notice of Availability of Draft Guidance Regarding Which Children’s Products are Subject to the Requirements of CPSIA Section 108.” Download Document Issues: OTC Medicines Children's Cough and Cold Medicines Pediatrics Medicine Other Issues Research Related Posts Comments Comments Regarding FDA Annual Reportable Labeling Changes for New Drug Applications and Abbreviated New Drug Applications for Nonprescription Drug Products May 13, 2024 Press Releases and Statements CHPA Applauds Vermont for Passing Sun Safety Bill Empowering Students to Better Protect their Skin May 8, 2024 Press Releases and Statements Tennessee Expands Access to OTC Cold & Allergy Medications Containing PSE May 7, 2024